Akari Therapeutics Plc (AKTX) KPIs and segments
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.70−0.81 (-12.44%)
Close on Nov 17, 2026Market cap $11.10MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Akari Therapeutics's business
Coming soon
This tab will track the numbers specific to Akari Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?